Reunion Neuroscience Presents Full Data from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD) at ACNP Annual Meeting

RE104 is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, which is administered via a single subcutaneous injection. Reunion designed RE104 to deliver a short, acute psychoactive ...
Seeking Alpha

Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide

1 Montgomery -Åsberg Depression Rating Scale (MADRS) scale range 0-60, higher scores indicating more severe depression. 2 Least Squares (LS) Means are means estimated from a linear model that are ...
Business Wire

Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in ...

- Interim readout shows rapid, robust, and clinically significant reduction of depression symptoms three weeks after a single 12mg dose, with an unprecedented mean -14 point Montgomery-Asberg ...
MedPage Today

Psilocybin Cut Depression Symptoms in COVID's Frontline Healthcare Workers

Psilocybin therapy reduced depression symptoms in clinicians who developed these symptoms after frontline clinical work during the COVID-19 pandemic, a small randomized trial showed. At day 28, the ...
BioWorld

Size MADRS, agency says; shortened scale could foil Alkermes' MDD adcom bid

BioWorld - Friday, December 8, 2023 See today's BioWorld Home » Size MADRS, agency says; shortened scale could foil Alkermes' MDD adcom bid X Upgrade your daily dose of biopharma and medtech news ...
Business Insider

Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide

SLS-002 versus placebo demonstrated early and persistent reductions in symptoms of depression as assessed by the Montgomery -Åsberg Depression Rating Scale (MADRS) 1. The graph presents results from ...